Oritinib
Product Specifications
CAS Number
2035089-28-0
Target
EGFR
Related Pathways
JAK/STAT signaling, Angiogenesis, Tyrosine Kinase/Adaptors
Purity
0.9962
Bioactivity
Oritinib (SH-1028) is an inhibitor of EGFR with IC50s of 18, 0.7, 4, 0.1, 1.4 and 0.89 nM for EGFR (wt), EGFR (L858R), EGFR (L861Q), EGFR (L858R/T790M), EGFR (d746-750), EGFR (d746-750/T790M), respectively. Oritinib can be used in studies about the treatment of non-small cell lung cancer.
Smiles
COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1c2CCCCn2c2ccccc12
Molecular Formula
C31H37N7O2
Molecular Weight
539.67
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
P9103-73J1-ML550 100 µL
Protein Kinase D2, ID (Serine/Threonine-protein Kinase D2, nPKC-D2, PRKD2, PKD2, HSPC187) (MaxLight 550) discontinued
Sign In for Pricing
View Details 
F4149-08 5 µg
Fgr, active, Recombinant, Human (SRC2, c-FGR, p55 c-fgr, Human Gardner-Rasheed feline viral oncogene) discontinued
Sign In for Pricing
View Details